MKI67 and neoplasm: Our results (Fig. 5e) showed that C-DVM treatment led to suppression of CD31 (a marker of angiogenesis), Ki-67 (related to tumor proliferation potential) and fibronectin (related to metastatic foci invasion), which led to a reduction in metastatic foci.